Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma
Arikan, Meltem Cevik
Smith, T. W.
Dresser, Karen A.
UMass Chan AffiliationsDivision of Neurosurgery, Department of Pathology, Department of Radiology, Department of Surgery
Document TypeJournal Article
Fatty Acid-Binding Proteins
MetadataShow full item record
AbstractAIMS: Glioblastoma (GBM) is the most common and aggressive primary brain tumour in adults. Angiogenesis and vasculogenesis play key roles in progression of GBMs. Fatty acid binding protein 4 (FABP4) is an intracellular chaperone for free fatty acids. FABP4 is detected in microvascular endothelial cells (ECs) in several normal tissues and promotes proliferation of ECs. The goal of this study was to characterize the tissue distribution pattern of FABP4 in GBMs. METHODS: Immunohistochemistry for FABP4 was performed on paraffin-embedded tumour sections and the intensity and distribution of FABP4 immunoreactivity were analysed. Double immunofluorescence was employed for detailed characterization of FABP4-positive cells. RESULTS: FABP4 immunoreactivity was absent in normal brain tissue sections. FABP4-positive cells were detected in 33%, 43%, 64% and 89% of Grade I, Grade II, Grade III and Grade IV glial tumours, respectively. Thus, the percentage of FABP4-positive cells in GBMs was significantly higher than lower-grade gliomas. In general, FABP4-expressing cells were distributed in a non-homogenous pattern, as 'hot spots' in glial tumours. FABP4 expression was detected in a subset of vascular ECs as well as some non-ECs. CONCLUSION: FABP4 is expressed in a significantly higher percentage of GBMs in comparison to both normal brain tissues and lower-grade glial tumours. FABP4 is expressed in some tumour ECs as well as non-ECs in glial tumours. As FABP4 promotes proliferation of ECs, detection of FABP4 in GBM-ECs, but not normal brain ECs suggests that FABP4 may play a role in the robust angiogenesis associated with GBMs. Neuropathological Society.
SourceNeuropathol Appl Neurobiol. 2012 Aug;38(5):400-10. doi: 10.1111/j.1365-2990.2011.01237.x. Link to article on publisher's site
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/47930
Related ResourcesLink to Article in PubMed